Klas Bratteby

发表

Development of 18F-Labeled Bispyridyl Tetrazines for In Vivo Pretargeted PET Imaging

A. Kjær, J. Jørgensen, V. Shalgunov, 2022, Pharmaceuticals.

Development of the First Aliphatic 18F-Labeled Tetrazine Suitable for Pretargeted PET Imaging-Expanding the Bio-orthogonal Tool Box.

A. Kjær, J. Jørgensen, V. Shalgunov, 2021, Journal of medicinal chemistry.

Lipophilicity and Click Reactivity Determine the Performance of Bioorthogonal Tetrazine Tools in Pretargeted In Vivo Chemistry

A. Kjaer, J. Jørgensen, K. Nørregaard, 2020, ACS pharmacology & translational science.

Insights into Elution of Anion Exchange Cartridges: Opening the Path toward Aliphatic 18F-Radiolabeling of Base-Sensitive Tracers

T. Ohlsson, V. Shalgunov, M. Herth, 2021, ACS pharmacology & translational science.

Aliphatic 18F‐Radiofluorination: Recent Advances in the Labeling of Base‐Sensitive Substrates **

V. Shalgunov, M. Herth, Klas Bratteby, 2021, ChemMedChem.

In Vivo Veritas - 18F-radiolabeled glycomimetics allow insights into the pharmacological fate of galectin-3 inhibitors.

V. Shalgunov, M. Herth, U. Nilsson, 2019, Journal of medicinal chemistry.

Fully Automated GMP-Compliant Synthesis of [18F]FE-PE2I

T. Ohlsson, J. Madsen, S. Lehel, 2021, Pharmaceuticals.

Quantitative Mass Spectrometry To Study Inflammatory Cartilage Degradation and Resulting Interactions with the Complement System

A. Blom, J. Malmström, E. Åhrman, 2016, The Journal of Immunology.

Optimized, automated and cGMP-compliant synthesis of the HER2 targeting [68Ga]Ga-ABY-025 tracer

J. Feldwisch, Mélodie Ferrat, Klas Bratteby, 2023, EJNMMI Radiopharmacy and Chemistry.